Country: United States
Language: English
Source: NLM (National Library of Medicine)
ENROFLOXACIN (UNII: 3DX3XEK1BN) (ENROFLOXACIN - UNII:3DX3XEK1BN)
Elanco US Inc.
SUBCUTANEOUS
PRESCRIPTION
Cattle - Single-Dose Therapy: Baytril 100 is indicated for the treatment of bovine respiratory disease (BRD) associated with Mannheimia haemolytica, Pasteurella multocida, Histophilus somni and Mycoplasma bovis in beef and non-lactating dairy cattle; and for the control of BRD in beef and non-lactating dairy cattle at high risk of developing BRD associated with M. haemolytica, P. multocida, H. somni and M. bovis . Cattle - Multiple-Day Therapy: Baytril 100 is indicated for the treatment of bovine respiratory disease (BRD) associated with Mannheimia haemolytica, Pasteurella multocida and Histophilus somni in beef and non-lactating dairy cattle. Swine: Baytril 100 is indicated for the treatment and control of swine respiratory disease (SRD) associated with Actinobacillus pleuropneumoniae, Pasteurella multocida, Haemophilus parasuis, Streptococcus suis, Bordetella bronchiseptica and Mycoplasma hyopneumoniae. Baytril 100 is indicated for the control of colibacillosis in groups or pens of weaned pigs whe
Baytril® 100: 100 mg/mL 100 mL Bottle 100 mg/mL 250 mL Bottle 100 mg/mL 500 mL Bottle REFERENCES: For product questions, to report adverse reactions, or for a copy of the Safety Data Sheet (SDS), call Elanco Product & Veterinary Support at 1-800-428-4441. Elanco 90206956_PA600217X Revised: January 2022 Baytril is sold by Elanco or its affiliates and is not a product of Bayer. The product name Baytril is owned by Bayer and used under license. Elanco and the diagonal bar logo are trademarks of Elanco or its affiliates. © 2022 Elanco or its affiliates. Baytril® 100 Approved by FDA under NADA # 141-068 Manufactured for: Elanco US Inc. Greenfield, IN 46140 U.S.A Made in Germany
New Animal Drug Application
BAYTRIL- ENROFLOXACIN INJECTION, SOLUTION ELANCO US INC. ---------- _ELANCO_™ BAYTRIL 100 (enrofloxacin) 100 MG/ML ANTIMICROBIAL INJECTABLE SOLUTION For Subcutaneous Use In Beef Cattle And Non-Lactating Dairy Cattle For Intramuscular Or Subcutaneous Use In Swine Not For Use In Female Dairy Cattle 20 Months Of Age Or Older Or In Calves To Be Processed For Veal CAUTION: Federal (U.S.A.) law restricts this drug to use by or on the order of a licensed veterinarian. Federal (U.S.A.) law prohibits the extra-label use of this drug in food-producing animals. To assure responsible antimicrobial drug use, enrofloxacin should only be used as a second-line drug for colibacillosis in swine following consideration of other therapeutic options. PRODUCT DESCRIPTION: Baytril 100 is a sterile, ready-to-use injectable antimicrobial solution that contains enrofloxacin, a broad-spectrum fluoroquinolone antimicrobial agent. Each mL of Baytril 100 contains 100 mg of enrofloxacin. Excipients are L-arginine base 200 mg, n-butyl alcohol 30 mg, benzyl alcohol (as a preservative) 20 mg and water for injection q.s. CHEMICAL NOMENCLATURE AND STRUCTURE: 1-cyclopropyl-7-(4-ethyl-1-piperazinyl)-6-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid. INDICATIONS: CATTLE - SINGLE-DOSE THERAPY: Baytril 100 is indicated for the treatment of bovine respiratory disease (BRD) associated with _Mannheimia haemolytica, Pasteurella_ ® _multocida, Histophilus somni_ and _Mycoplasma bovis_ in beef and non-lactating dairy cattle; and for the control of BRD in beef and non-lactating dairy cattle at high risk of developing BRD associated with _M. haemolytica, P. multocida, H. somni_ and _M. bovis_. CATTLE - MULTIPLE-DAY THERAPY: Baytril 100 is indicated for the treatment of bovine respiratory disease (BRD) associated with _Mannheimia haemolytica, Pasteurella_ _multocida_ and _Histophilus somni_ in beef and non-lactating dairy cattle. SWINE: Baytril 100 is indicated for the treatment and control of swine respiratory disease (SRD) associated with _Actinobacillu Read the complete document